Using CRISPR to edit the cancer genome, our results show that introduction of a single point mutation into the Meth A tumor results in strong transcriptomic signatures of TCR engagement and cytotoxic functions in the CD8 T cells infiltrating the tumor. This evidence concerns the gene CD8A and cancer.